Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease
|ClinicalTrials.gov Identifier: NCT00095472|
Recruitment Status : Completed
First Posted : November 5, 2004
Last Update Posted : June 18, 2018
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||August 24, 2007|
|Actual Study Completion Date :||August 24, 2007|
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373-6.
Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987 Dec;61(6):866-79.